Similar articles

• Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

  Eng C, Mulligan LM. Eng C, et al. Hum Mutat. 1997;9(2):97-109. doi: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M. Hum Mutat. 1997. PMID: 9067749 Review.
• RET mutations in human disease.

  Pasini B, Ceccherini I, Romeo G. Pasini B, et al. Trends Genet. 1996 Apr;12(4):138-44. doi: 10.1016/0168-9525(96)10012-3. Trends Genet. 1996. PMID: 8901418 Review.
• Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene.

  Tsai MS, Ledger GA, Khosla S, Gharib H, Thibodeau SN. Tsai MS, et al. J Clin Endocrinol Metab. 1994 May;78(5):1261-4. doi: 10.1210/jcem.78.5.7909818. J Clin Endocrinol Metab. 1994. PMID: 7909818
• Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.

  Ponder BA. Ponder BA. Cancer Surv. 1995;25:195-205. Cancer Surv. 1995. PMID: 8718519 Review. No abstract available.
• RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.

  Kim IJ, Kang HC, Park JH, Ku JL, Lee JS, Kwon HJ, Yoon KA, Heo SC, Yang HY, Cho BY, Kim SY, Oh SK, Youn YK, Park DJ, Lee MS, Lee KW, Park JG. Kim IJ, et al. Clin Cancer Res. 2002 Feb;8(2):457-63. Clin Cancer Res. 2002. PMID: 11839664